209 related articles for article (PubMed ID: 23248292)
1. Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2.
Arlow T; Scott K; Wagenseller A; Gammie A
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):246-51. PubMed ID: 23248292
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.
Gammie AE; Erdeniz N; Beaver J; Devlin B; Nanji A; Rose MD
Genetics; 2007 Oct; 177(2):707-21. PubMed ID: 17720936
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pathogenic human MSH2 missense mutations using yeast as a model system: a laboratory course in molecular biology.
Gammie AE; Erdeniz N
Cell Biol Educ; 2004; 3(1):31-48. PubMed ID: 22039344
[TBL] [Abstract][Full Text] [Related]
6. Separation-of-function mutations in Saccharomyces cerevisiae MSH2 that confer mismatch repair defects but do not affect nonhomologous-tail removal during recombination.
Studamire B; Price G; Sugawara N; Haber JE; Alani E
Mol Cell Biol; 1999 Nov; 19(11):7558-67. PubMed ID: 10523644
[TBL] [Abstract][Full Text] [Related]
7. MutSα mismatch repair protein stability is governed by subunit interaction, acetylation, and ubiquitination.
Arlow T; Kim J; Haye-Bertolozzi JE; Martínez CB; Fay C; Zorensky E; Rose MD; Gammie AE
G3 (Bethesda); 2021 Apr; 11(3):. PubMed ID: 33793773
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo.
Mastrocola AS; Heinen CD
Hum Mutat; 2010 Oct; 31(10):E1699-708. PubMed ID: 20672385
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of pathogenicity in human MSH2 missense mutants.
Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M
Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317
[TBL] [Abstract][Full Text] [Related]
11. Cell-cycle and DNA damage regulation of the DNA mismatch repair protein Msh2 occurs at the transcriptional and post-transcriptional level.
Tennen RI; Haye JE; Wijayatilake HD; Arlow T; Ponzio D; Gammie AE
DNA Repair (Amst); 2013 Feb; 12(2):97-109. PubMed ID: 23261051
[TBL] [Abstract][Full Text] [Related]
12. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.
Wielders E; Delzenne-Goette E; Dekker R; van der Valk M; Te Riele H
Fam Cancer; 2017 Apr; 16(2):221-229. PubMed ID: 27873144
[TBL] [Abstract][Full Text] [Related]
13. Multiplexing mutation rate assessment: determining pathogenicity of Msh2 variants in Saccharomyces cerevisiae.
Ollodart AR; Yeh CC; Miller AW; Shirts BH; Gordon AS; Dunham MJ
Genetics; 2021 Jun; 218(2):. PubMed ID: 33848333
[TBL] [Abstract][Full Text] [Related]
14. Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk.
Jia X; Burugula BB; Chen V; Lemons RM; Jayakody S; Maksutova M; Kitzman JO
Am J Hum Genet; 2021 Jan; 108(1):163-175. PubMed ID: 33357406
[TBL] [Abstract][Full Text] [Related]
15. ATP binding and hydrolysis by Saccharomyces cerevisiae Msh2-Msh3 are differentially modulated by mismatch and double-strand break repair DNA substrates.
Kumar C; Eichmiller R; Wang B; Williams GM; Bianco PR; Surtees JA
DNA Repair (Amst); 2014 Jun; 18():18-30. PubMed ID: 24746922
[TBL] [Abstract][Full Text] [Related]
16. Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.
Rath A; Mishra A; Ferreira VD; Hu C; Omerza G; Kelly K; Hesse A; Reddi HV; Grady JP; Heinen CD
Hum Mutat; 2019 Nov; 40(11):2044-2056. PubMed ID: 31237724
[TBL] [Abstract][Full Text] [Related]
17. A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.
Bianchi F; Maccaroni E; Belvederesi L; Brugiati C; Giampieri R; Bini F; Bracci R; Pagliaretta S; Del Prete M; Piva F; Mandolesi A; Scarpelli M; Berardi R
Fam Cancer; 2018 Apr; 17(2):215-224. PubMed ID: 28785832
[TBL] [Abstract][Full Text] [Related]
18. The properties of Msh2-Msh6 ATP binding mutants suggest a signal amplification mechanism in DNA mismatch repair.
Graham WJ; Putnam CD; Kolodner RD
J Biol Chem; 2018 Nov; 293(47):18055-18070. PubMed ID: 30237169
[TBL] [Abstract][Full Text] [Related]
19. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).
Chao EC; Velasquez JL; Witherspoon MS; Rozek LS; Peel D; Ng P; Gruber SB; Watson P; Rennert G; Anton-Culver H; Lynch H; Lipkin SM
Hum Mutat; 2008 Jun; 29(6):852-60. PubMed ID: 18383312
[TBL] [Abstract][Full Text] [Related]
20. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
